These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24038082)

  • 1. Novel molecular mechanisms of neuromuscular disease: implications for therapy. Abstracts of the Muscle Study Group Meeting. September 16-18, 2013. Oxford, United Kingdom.
    Muscle Nerve; 2013 Sep; 48 Suppl 1():S1-13. PubMed ID: 24038082
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular disease: muscle.
    Fardeau M
    Curr Opin Neurol; 2013 Oct; 26(5):516-8. PubMed ID: 23995280
    [No Abstract]   [Full Text] [Related]  

  • 3. Report on the 3rd Ottawa International Conference on Neuromuscular Biology, Disease and Therapy - September 24-26, 2015, Ottawa, Canada.
    Chardon JW; Jasmin BJ; Kothary R; Parks RJ
    J Neuromuscul Dis; 2016 Aug; 3(3):431-442. PubMed ID: 27854234
    [No Abstract]   [Full Text] [Related]  

  • 4. Current concerns in the therapy of neuromuscular disorders.
    Dubowitz V
    Neuromuscul Disord; 2011 Jan; 21(1):3. PubMed ID: 21130653
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hereditary neuromuscular diseases].
    Abramova MF
    Med Sestra; 1989 Oct; 48(10):19-23. PubMed ID: 2615614
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuromuscular diseases: progress in gene discovery drives diagnostics and therapeutics.
    Fratta P; Hanna MG
    Lancet Neurol; 2015 Jan; 14(1):13-4. PubMed ID: 25496885
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuromuscular disease: new insights and avenues for therapy.
    Scotter EL; Shaw CE
    Lancet Neurol; 2013 Jan; 12(1):13-5. PubMed ID: 23237893
    [No Abstract]   [Full Text] [Related]  

  • 8. A 2020 centenary perspective on neuromuscular disorders.
    Goutman SA; Callaghan BC; Feldman E
    J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):791-792. PubMed ID: 32665324
    [No Abstract]   [Full Text] [Related]  

  • 9. Developing new treatments for muscle disease: prospects and promise.
    Griggs RC
    Curr Opin Neurol; 1994 Oct; 7(5):422-6. PubMed ID: 7804463
    [No Abstract]   [Full Text] [Related]  

  • 10. New therapies for neuromuscular diseases in 2018.
    Shah AM; Al-Chalabi A
    Lancet Neurol; 2019 Jan; 18(1):12-13. PubMed ID: 30563673
    [No Abstract]   [Full Text] [Related]  

  • 11. Bibliography. Current world literature. Neuromuscular disease: muscle.
    Curr Opin Neurol; 2000 Oct; 13(5):593-601. PubMed ID: 11073369
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuromuscular diseases. Molecular genetic methods will revolutionize diagnosis and treatment].
    Anvret M; Edström L; Ahlberg G
    Lakartidningen; 1992 Mar; 89(11):862, 865-9. PubMed ID: 1545641
    [No Abstract]   [Full Text] [Related]  

  • 13. New treatments for neuromuscular disease: optimism and obstacles.
    Lochmüller H; Griggs RC
    Neurotherapeutics; 2008 Oct; 5(4):497-8. PubMed ID: 19019299
    [No Abstract]   [Full Text] [Related]  

  • 14. Antisense oligonucleotides for therapeutic interventions in neuromuscular diseases.
    Danos O
    Hum Gene Ther; 2013 May; 24(5):470-1. PubMed ID: 23675648
    [No Abstract]   [Full Text] [Related]  

  • 15. Opportunities and challenges for the development of antisense treatment in neuromuscular disorders.
    van Putten M; Aartsma-Rus A
    Expert Opin Biol Ther; 2011 Aug; 11(8):1025-37. PubMed ID: 21510827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular Disorders in Children and Adolescents.
    Korinthenberg R
    Neuropediatrics; 2017 Aug; 48(4):209-210. PubMed ID: 28738441
    [No Abstract]   [Full Text] [Related]  

  • 17. Inherited neuromuscular diseases. Translation from pathomechanisms to therapies.
    Espinós C; Felipo V; Palau F
    Adv Exp Med Biol; 2009; 652():v-vi. PubMed ID: 20235380
    [No Abstract]   [Full Text] [Related]  

  • 18. Paediatric neurology: from molecular mechanisms to targeted treatments.
    Muntoni F; Cross JH
    Lancet Neurol; 2015 Jan; 14(1):16-8. PubMed ID: 25496887
    [No Abstract]   [Full Text] [Related]  

  • 19. VII International Congress on neuromuscular diseases, Munich, September 16-22, 1990.
    Kakulas BA; Byrne E
    Brain Pathol; 1991 Jan; 1(2):135-6. PubMed ID: 1688298
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy update in nerve, neuromuscular junction and myopathic disorders.
    Sadeghian H; Wolfe GI
    Curr Opin Neurol; 2010 Oct; 23(5):496-501. PubMed ID: 20664347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.